Ann Lee

Ann Lee

Technik-/Wissenschafts-/F&E-Leiter bei PRIME MEDICINE, INC.

Vermögen: 471 252 $ am 30.06.2026

64 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Dr. Ann L.
Lee
is a Chief Technical Officer at Prime Medicine, Inc., an Independent Director at Coya Therapeutics, Inc., a Member at National Academy of Engineering and a Member at Washington State Academy of Sciences.
She is on the Board of Directors at Coya Therapeutics, Inc., Alliance for Regenerative Medicine, American Institute of Chemical Engineers and JW Therapeutics (Shanghai) Co., Ltd. Dr. Lee was previously employed as a SVP, Head of Cell Therapy Development & Operations by Bristol Myers Squibb Co., an EVP-Cell Therapy Development & Operations by Celgene Corp., an Executive Vice President-Technical Operations by Juno Therapeutics, Inc., a SVP & Head-Global Technical Development by Roche Corp., a SVP, Global Head-Pharma Technical Development by Genentech, Inc., a VP-Process Engineering & Technical Operations by Merck & Co., Inc., and a VP-Chemical Technology & Engineering by Merck Research Laboratories Massachusetts LLC.
She also served on the board at JW (Cayman) Therapeutics Co. Ltd. She received her undergraduate degree from Cornell University, a graduate degree from Yale University and a doctorate degree from Yale University.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
31.03.2026 100’000 ( 0.06% ) 369 000 $ 30.06.2026
01.05.2026 17’479 ( 0.07% ) 102 252 $ 30.06.2026

Aktive Positionen von Ann Lee

UnternehmenPositionBeginn
PRIME MEDICINE, INC. Technik-/Wissenschafts-/F&E-Leiter 01.10.2021
COYA THERAPEUTICS, INC. Direktor/Vorstandsmitglied 01.06.2021
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Corporate Officer/Principal -
Direktor/Vorstandsmitglied -
Corporate Officer/Principal -

Ehemalige bekannte Positionen von Ann Lee

UnternehmenPositionEnde
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01.07.2021
CELGENE Corporate Officer/Principal 01.11.2019
░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Ann Lee im Detail an

Ausbildung von Ann Lee

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

90

Beziehungen ersten Grades

17

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen17

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Health Technology

Roche Corp.

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services